Quantcast

Latest AcelRx Pharmaceuticals Inc. Stories

2015-05-04 16:34:43

REDWOOD CITY, Calif., May 4, 2015 /PRNewswire/ -- AcelRx Pharmaceuticals, Inc.

2015-05-01 08:26:55

REDWOOD CITY, Calif., May 1, 2015 AcelRx Pharmaceuticals, Inc.

2015-04-30 08:39:13

REDWOOD CITY, Calif., April 30, 2015 /PRNewswire/ -- AcelRx Pharmaceuticals, Inc.

2015-04-14 08:28:56

Clinical Data from Two Different Development Programs Highlight Efficacy and Tolerability of Sublingual Sufentanil in Out-patient and In-patient Surgical Populations REDWOOD CITY,

2015-03-20 16:23:33

AcelRx Announces Restructuring to Focus on Regulatory Approval of Zalviso and Clinical Development of ARX-04 REDWOOD CITY, Calif., March 20, 2015 /PRNewswire/ -- AcelRx Pharmaceuticals, Inc.

2015-03-16 08:30:34

SAP301 Trial to Study Sufentanil Sublingual Single-Dose Tablet for the Treatment of Moderate-to-Severe Acute Pain REDWOOD CITY, Calif., March 16, 2015 /PRNewswire/ -- AcelRx Pharmaceuticals,

2015-03-09 16:34:07

REDWOOD CITY, Calif., March 9, 2015 /PRNewswire/ -- AcelRx Pharmaceuticals, Inc.

2015-03-09 08:29:22

REDWOOD CITY, Calif., March 9, 2015 /PRNewswire/ -- AcelRx Pharmaceuticals, Inc.

2015-03-04 08:30:32

REDWOOD CITY, Calif., March 4, 2015 /PRNewswire/ -- AcelRx Pharmaceuticals, Inc.

2015-02-20 08:26:33

REDWOOD CITY, Calif., Feb. 20, 2015 /PRNewswire/ -- AcelRx Pharmaceuticals, Inc.